Latest News in the pharma Industry

Top Stories

FDA Approves Generic Olanzapine

FDA Approves Generic Olanzapine

25 Oct 2011

The FDA has approved generic olanzapine tablets and generic olanzapine orally disintegrating tablets to treat schizophrenia and bipolar disorder.

Read more 
MSD Expands in Singapore with New Investments

MSD Expands in Singapore with New Investments

24 Oct 2011

Under the agreement, MSD will invest over USD $250 million over the next ten years in site improvements at its manufacturing facilities in Singapore.

Read more 
Syntaxin & Ipsen Ink Botulinum Therapeutic Pact

Syntaxin & Ipsen Ink Botulinum Therapeutic Pact

24 Oct 2011

Syntaxin will be responsible for the discovery of new therapeutic candidates and Ipsen will apply its pharmacological, preclinical and clinical assessments of the discovered compounds.

Read more 
Prasco & Eli Lilly Sign Agreement for Generics

Prasco & Eli Lilly Sign Agreement for Generics

21 Oct 2011

Prasco Laboratories and Eli Lilly have signed a marketing and distribution agreement for two generic products in the U.S. market.

Read more 
Evotec & Apeiron Ink Discovery Pact for Anti-tumor Immune Therapy

Evotec & Apeiron Ink Discovery Pact for Anti-tumor Immune Therapy

21 Oct 2011

Evotec and Apeiron Biologics have entered into a discovery project on the Cbl-b target for an anti-tumor immune therapy.

Read more 
Abbott to Split into Two Pharma Businesses

Abbott to Split into Two Pharma Businesses

20 Oct 2011

Abbott plans to separate into two companies, one in diversified medical products and the other in research-based pharmaceuticals.

Read more 
Novartis & SomaLogic Sign Research Deal for Proteomics Technology

Novartis & SomaLogic Sign Research Deal for Proteomics Technology

20 Oct 2011

SomaLogic has signed a multi-year research agreement with Novartis to use its proteomics technology to accelerate Novartis' drug discovery.

Read more 
Veteran's New Target: A Story from Mark Roberts, Founder of Roberts Chemicals

Veteran's New Target: A Story from Mark Roberts, Founder of Roberts Chemicals

19 Oct 2011

A 30-year veteran of the fine chemicals industry has launched his own business, with a new model.

Read more 
Servier & Miragen Ink $352M Partnership Deal

Servier & Miragen Ink $352M Partnership Deal

19 Oct 2011

Under the partnership, the two companies will advance the research, development and commercialization of three drug candidates.

Read more 
Jubilant Biosys & Norgine Enter into Discovery Agreement

Jubilant Biosys & Norgine Enter into Discovery Agreement

19 Oct 2011

Under the agreement, Jubilant will deliver preclinical candidates and Norgine will have rights to further development and commercialization of treatments in the area of gastrointestinal disease.

Read more 
WHO: Widely Available Treatments Keeping Malaria under Better Control

WHO: Widely Available Treatments Keeping Malaria under Better Control

19 Oct 2011

A WHO report says one-third of the 108 countries, where malaria was endemic, were on course to eradicate the disease within ten years.

Read more 
Roche to Acquire Anadys for $230M

Roche to Acquire Anadys for $230M

18 Oct 2011

Roche is to acquire Anadys Pharmaceuticals for $230 million in cash to strenthen its HCV portfolio.

Read more